iScience (Sep 2021)

ASCL1, NKX2-1, and PROX1 co-regulate subtype-specific genes in small-cell lung cancer

  • Karine Pozo,
  • Rahul K. Kollipara,
  • Demetra P. Kelenis,
  • Kathia E. Rodarte,
  • Morgan S. Ullrich,
  • Xiaoyang Zhang,
  • John D. Minna,
  • Jane E. Johnson

Journal volume & issue
Vol. 24, no. 9
p. 102953

Abstract

Read online

Summary: Lineage-defining transcription factors (LTFs) play key roles in small-cell lung cancer (SCLC) pathophysiology. Delineating the LTF-regulated genes operative in SCLC could provide a road map to identify SCLC dependencies. We integrated chromatin landscape and transcriptome analyses of patient-derived SCLC preclinical models to identify super-enhancers (SEs) and their associated genes in the ASCL1-, NEUROD1-, and POU2F3-high SCLC subtypes. We find SE signatures predict LTF-based classification of SCLC, and the SE-associated genes are enriched with those defined as common essential genes in DepMap. In addition, in ASCL1-high SCLC, we show ASCL1 complexes with NKX2-1 and PROX1 to co-regulate genes functioning in NOTCH signaling, catecholamine biosynthesis, and cell-cycle processes. Depletion of ASCL1 demonstrates it is a key dependency factor in preclinical SCLC models and directly regulates multiple DepMap-defined essential genes. We provide LTF/SE-based subtype-specific gene sets for SCLC for further therapeutic investigation.

Keywords